Combined Metformin and Insulin Treatment Reverses Metabolically Impaired Omental Adipogenesis and Accumulation of 4-hydroxynonenal in Obese Diabetic Patients

Overview

Journal Redox Biol

Specialties Biology
Cell Biology
Endocrinology

Date 2017 Mar 24

PMID 28334683

Citations 28

Authors

Morana Jaganjac

Shamma Almuraikhy

Fatima Al-Khelaifi

Mashael Al-Jaber

Moataz Bashah

Nayef A Mazloum

Kamelija Zarkovic

Neven Zarkovic

Georg Waeg

Wael Kafienah

Mohamed A Elrayess

Affiliations

Soon will be listed here.

Abstract

Objective: Obesity-associated impaired fat accumulation in the visceral adipose tissue can lead to ectopic fat deposition and increased risk of insulin resistance and type 2 diabetes mellitus (T2DM). This study investigated whether impaired adipogenesis of omental (OM) adipose tissues and elevated 4-hydroxynonenal (4-HNE) accumulation contribute to this process, and if combined metformin and insulin treatment in T2DM patients could rescue this phenotype.

Methods: OM adipose tissues were obtained from forty clinically well characterized obese individuals during weight reduction surgery. Levels of 4-HNE protein adducts, adipocyte size and number of macrophages were determined within these tissues by immunohistochemistry. Adipogenic capacity and gene expression profiles were assessed in preadipocytes derived from these tissues in relation to insulin resistance and in response to 4-HNE, metformin or combined metformin and insulin treatment.

Results: Preadipocytes isolated from insulin resistant (IR) and T2DM individuals exhibited lower adipogenesis, marked by upregulation of anti-adipogenic genes, compared to preadipocytes derived from insulin sensitive (IS) individuals. Impaired adipogenesis was also associated with increased 4-HNE levels, smaller adipocytes and greater macrophage presence in the adipose tissues. Within the T2DM group, preadipocytes from combined metformin and insulin treated subset showed better in vitro adipogenesis compared to metformin alone, which was associated with less presence of macrophages and 4-HNE in the adipose tissues. Treatment of preadipocytes in vitro with 4-HNE reduced their adipogenesis and increased proliferation, even in the presence of metformin, which was partially rescued by the presence of insulin.

Conclusion: This study reveals involvement of 4-HNE in the impaired OM adipogenesis-associated with insulin resistance and T2DM and provides a proof of concept that this impairment can be reversed by the synergistic action of insulin and metformin. Further studies are needed to evaluate involvement of 4-HNE in metabolically impaired abdominal adipogenesis and to confirm benefits of combined metformin-insulin therapy in T2DM patients.

Citing Articles

Understanding the link between ALDH2 genotypes and diabetes.

Peng M, Liu R, Zhang J, Kong W, Zheng J, Hu X Front Endocrinol (Lausanne). 2025; 16:1451722.

PMID: 40046877 PMC: 11879816. DOI: 10.3389/fendo.2025.1451722.

Regional primary preadipocyte characteristics in humans with obesity and type 2 diabetes mellitus.

Plissonneau C, Santosa S Heliyon. 2024; 10(21):e39710.

PMID: 39553621 PMC: 11564010. DOI: 10.1016/j.heliyon.2024.e39710.

Accumulation of 4-Hydroxynonenal Characterizes Diabetic Fat and Modulates Adipogenic Differentiation of Adipose Precursor Cells.

Murdolo G, Bartolini D, Tortoioli C, Vermigli C, Piroddi M, Galli F Int J Mol Sci. 2023; 24(23).

PMID: 38068967 PMC: 10705911. DOI: 10.3390/ijms242316645.

The 4-Hydroxynonenal-Protein Adducts and Their Biological Relevance: Are Some Proteins Preferred Targets?.

Milkovic L, Zarkovic N, Marusic Z, Zarkovic K, Jaganjac M Antioxidants (Basel). 2023; 12(4).

PMID: 37107229 PMC: 10135105. DOI: 10.3390/antiox12040856.

Relationship between 4-Hydroxynonenal (4-HNE) as Systemic Biomarker of Lipid Peroxidation and Metabolomic Profiling of Patients with Prostate Cancer.

Nikolac Perkovic M, Jaganjac M, Milkovic L, Horvat T, Rojo D, Zarkovic K Biomolecules. 2023; 13(1).

PMID: 36671530 PMC: 9855859. DOI: 10.3390/biom13010145.

References

Lenhard J, Kliewer S, Paulik M, Plunket K, Lehmann J, Weiel J . Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways. Biochem Pharmacol. 1997; 54(7):801-8. DOI: 10.1016/s0006-2952(97)00229-3. View

Alexandre K, Smit A, Gray I, Crowther N . Metformin inhibits intracellular lipid accumulation in the murine pre-adipocyte cell line, 3T3-L1. Diabetes Obes Metab. 2008; 10(8):688-90. DOI: 10.1111/j.1463-1326.2008.00890.x. View

Wulffele M, Kooy A, Lehert P, Bets D, Ogterop J, Borger van der Burg B . Combination of insulin and metformin in the treatment of type 2 diabetes. Diabetes Care. 2002; 25(12):2133-40. DOI: 10.2337/diacare.25.12.2133. View

Lee M, Wu Y, Fried S . A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes. Obesity (Silver Spring). 2012; 20(12):2334-40. PMC: 4320940. DOI: 10.1038/oby.2012.116. View

Irons B, Minze M . Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes Metab Syndr Obes. 2014; 7:15-24. PMC: 3900315. DOI: 10.2147/DMSO.S38753. View

Shi X, Shi W, Li Q, Song B, Wan M, Bai S . A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 2003; 4(4):374-80. PMC: 1319161. DOI: 10.1038/sj.embor.embor805. View

Almuraikhy S, Kafienah W, Bashah M, Diboun I, Jaganjac M, Al-Khelaifi F . Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance. Diabetologia. 2016; 59(11):2406-2416. PMC: 5506102. DOI: 10.1007/s00125-016-4031-3. View

Elrayess M, Almuraikhy S, Kafienah W, Al-Menhali A, Al-Khelaifi F, Bashah M . 4-hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance. Free Radic Biol Med. 2017; 104:129-137. DOI: 10.1016/j.freeradbiomed.2017.01.015. View

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-8. DOI: 10.1161/01.CIR.0000111245.75752.C6. View

10.

Jaganjac M, Poljak-Blazi M, Schaur R, Zarkovic K, Borovic S, Cipak A . Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression. Clin Exp Immunol. 2012; 170(2):178-85. PMC: 3482364. DOI: 10.1111/j.1365-2249.2012.04639.x. View

11.

Poljak-Blazi M, Jaganjac M, Sabol I, Mihaljevic B, Matovina M, Grce M . Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. Toxicol In Vitro. 2010; 25(1):160-6. DOI: 10.1016/j.tiv.2010.10.013. View

12.

Weber D, Milkovic L, Bennett S, Griffiths H, Zarkovic N, Grune T . Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol. 2013; 1:226-33. PMC: 3757688. DOI: 10.1016/j.redox.2013.01.012. View

13.

Garin-Shkolnik T, Rudich A, Hotamisligil G, Rubinstein M . FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues. Diabetes. 2013; 63(3):900-11. DOI: 10.2337/db13-0436. View

14.

Catalano K, Stefanovski D, Bergman R . Critical role of the mesenteric depot versus other intra-abdominal adipose depots in the development of insulin resistance in young rats. Diabetes. 2010; 59(6):1416-23. PMC: 2874702. DOI: 10.2337/db08-0675. View

15.

Huypens P, Quartier E, Pipeleers D, Van de Casteele M . Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase. Eur J Pharmacol. 2005; 518(2-3):90-5. DOI: 10.1016/j.ejphar.2005.06.016. View

16.

Bogardus C, Lillioja S, Mott D, Hollenbeck C, Reaven G . Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol. 1985; 248(3 Pt 1):E286-91. DOI: 10.1152/ajpendo.1985.248.3.E286. View

17.

Vazdar M, Jurkiewicz P, Hof M, Jungwirth P, Cwiklik L . Behavior of 4-hydroxynonenal in phospholipid membranes. J Phys Chem B. 2012; 116(22):6411-5. DOI: 10.1021/jp3044219. View

18.

Spickett C, Wiswedel I, Siems W, Zarkovic K, Zarkovic N . Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res. 2010; 44(10):1172-202. DOI: 10.3109/10715762.2010.498476. View

19.

Dasuri K, Ebenezer P, Fernandez-Kim S, Zhang L, Gao Z, Bruce-Keller A . Role of physiological levels of 4-hydroxynonenal on adipocyte biology: implications for obesity and metabolic syndrome. Free Radic Res. 2012; 47(1):8-19. PMC: 4038367. DOI: 10.3109/10715762.2012.733003. View

20.

Dandona P, Chaudhuri A, Mohanty P, Ghanim H . Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care. 2007; 10(4):511-7. DOI: 10.1097/MCO.0b013e3281e38774. View